POST Online Media Lite Edition



 

FibroBiologics appoints Hamid Khoja as chief scientific officer

Christian Fernsby |
Houston, Tx., USA - FibroBiologics, a clinical stage company, announced the appointment of Hamid Khoja as chief scientific officer.

Article continues below




Dr. Khoja will join FibroBiologics from Covaris where he served as Principal Scientist responsible for long-term strategic application and technology development for their unique proprietary technology.

Prior to Covaris, Dr. Khoja was a scientist at Genomic Solutions, Eli Lilly and Chiron Pharmaceuticals.

LATEST 5 MOVES FROM Texas